TMCnet News
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceWALTHAM, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that David Hering, Chief Executive Officer of Invivyd, is scheduled to present in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 1:00 p.m. ET in New York, NY. In addition to the fireside chat, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Invivyd management should contact their Guggenheim representative. A live webcast of the fireside chat will be available in the investor section of the company's website at investors.invivyd.com and will be archived for approximatly 30 days following the presentation. About Invivyd Contacts: Scott Young Gabriella Linville-Engler |